Disease Target Suppliers Serving Usa Delaware

Neoclease is at the forefront of advancing gene editing technologies with a mission to transform healthcare by curing genetic diseases rather than just treating them. Utilizing a bespoke approach, the company develops tailored nucleases designed to ...

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...

Founded in 2012, we are the leading pharmatech company and the first to automate drug discovery. As a full stack AI drug discovery company, we generate our own data before combining the analytical power of AI with the creativity and expertise of our ...

PROTIA Inc. aims to contribute to human health and well-being through finding new protein targets for disease prediction, early diagnosis, and development of new medicines. Based on our dedication for identification of bio-markers needed in early ...

MOBILion Systems is enabling advancements in disease diagnosis and treatment by commercializing instruments that improve multi-omics disease, drug, and biomarker discovery. Enhancing the study of the complement to genomics provides a better ...

EsoCap’s vision is to improve the lives of patients affected by esophageal diseases. The esophagus is a particularly challenging environment, as swallowed drugs only remain in the area between the mouth and the stomach for a few seconds. EsoCap, a ...

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early ...

At Benevolent we build technology in the service of science - to augment human intelligence and inspire the discovery of new medicines for the thousands of diseases that have no treatment. Building the right team is an art not a science. We strive ...

Established in 1979, Bio-Diagnostics is privately owned, rapidly growing, UK bio-tech business, based 40 miles south west of Birmingham, UK. Bio-Diagnostics is highly regarded and trusted globally, working closely with partners providing, ...

Imspex provides cutting-edge analytics solutions where early warning signals are needed. Our versatile combination of gas chromatography (GC) and ion mobility spectrometry (IMS) has already proven itself in medical detection and medical diagnosis ...

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...

ProteoGenex is an established, innovative provider of biological specimens and clinical information of the highest quality standards. We are a privately held US company founded in Los Angeles, CA in 2003. With headquarters in Los Angeles, CA, we ...

Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...

MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our ...

cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria ...

Biotest - innovation in haematology, clinical immunology and intensive care medicine. Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and ...

HistoSonics is developing a non-invasive, sonic beam therapy platform capable of destroying tissue at a sub-cellular level. Our mission and passion is to advance the novel science of histotripsy and its powerful benefits, bringing meaningful and ...

Vitassay develops and distributes reliable and certified solutions for the early detection of different pathogens which cause infectious diseases in humans. Our greatest asset is to offer a complete service for every customer to exceed their ...

Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...

Lumen Bioscience discovers, develops, and manufactures biologic drug candidates for highly prevalent diseases-many of which currently lack effective treatments. The company’s unique drug development and manufacturing platform offers the potential to ...